Dr. Dmitriy Zamarin, MD, PhD
- Medicare services, 2024
- 166
- Medicare patients, 2024
- 48
- Part D claims, 2024
- 130
- Publications
- 121
- Clinical trials
- 4
- Practice address
- 3201 Kings Hwy, Brooklyn, NY 11234
- Practice phone
- Call (646) 605-6009
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Mount Sinai - Brooklyn
Brooklyn, New York
Find Dr. Zamarin's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Dmitriy Zamarin is a medical oncologist in Brooklyn, New York
Dr. Zamarin practices at Mount Sinai - Brooklyn in Brooklyn, New York.
Dr. Zamarin's NPI, 1891955357, was assigned on June 9, 2008. Dr. Zamarin graduated from Icahn School Of Medicine At Mount Sinai in 2008. Dr. Zamarin holds New York license 254702.
- NPI
- 1891955357NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5395962476
- NPI enumeration date
- June 9, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (646) 605-6009
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 44
- Medical school graduation
- 2008
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Dmitriy Zamarin practices at Mount Sinai - Brooklyn in Brooklyn, New York
Dr. Zamarin's primary practice is Mount Sinai - Brooklyn, at 3201 Kings Hwy, Brooklyn, NY 11234 in Kings County. The practice phone is (646) 605-6009.
- Mount Sinai - Brooklyn3201 Kings Hwy, Brooklyn, NY 11234 · Kings CountyPhone(646) 605-6009
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Dmitriy Zamarin is affiliated with 4 sites of care and 1 medical group
Dr. Zamarin's primary practice is Mount Sinai - Brooklyn in Brooklyn, New York. Dr. Zamarin is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Zamarin to 1 more hospital and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Dmitriy Zamarin's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zamarin practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Mount Sinai - Brooklyn | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Dmitriy Zamarin is one of 458 medical oncologists in New York
Medical oncology is Dr. Zamarin's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Zamarin is licensed in New York.
Specialties and state licenses
- Medical oncology, New YorkPrimary
Medical oncologists near Dr. Zamarin
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Dmitriy Zamarin billed Medicare for 166 services in 2024
CMS data shows 166 Medicare services from Dr. Zamarin across 3 procedure codes in 2024, for 48 Medicare patients. Medicare paid $15,258 for them.
Dr. Zamarin's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1282024: 16630%
Where Dr. Zamarin's Medicare services took place, 2024
- In an office13783%
- In a facility2917%
Dr. Zamarin compared with the New York median for medical oncologists, 2024
- Dr. Zamarin
- New York median
- Medicare services
- 166vs 34051% below
- Medicare patients
- 48vs 11257% below
- Part D claims
- 48vs 13063% below
Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.
Dr. Zamarin's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Zamarin?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Zamarin and other medical oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Dmitriy Zamarin treated 48 Medicare patients in 2024, average age 73
CMS counts 48 Medicare patients who saw Dr. Zamarin in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have cancer, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Zamarin's median patient age at 65, with 82% women.
Dr. Zamarin's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Zamarin's Medicare patients by sex, 2024
- Women3777%
- Men1123%
Chronic conditions among Dr. Zamarin's Medicare patients, 2024
- Cancer75%
- High cholesterol75%
- High blood pressure73%
- Arthritis44%
- Diabetes42%
- Mood disorders42%
- Depression38%
- Anxiety33%
Share of Medicare patients with each condition. A patient can have several.
Dr. Zamarin's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 65
Patient panel by sex, all payers
- Women82%
- Men17%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Dmitriy Zamarin wrote 130 Medicare Part D claims in 2024
In 2024, Dr. Zamarin wrote 130 Medicare Part D claims for 25 patients. 88% of them were for generic drugs. CMS names the drug for 48 of them, across 3 drugs with 11 or more claims each, at $461 in total drug cost. In 2023, CMS named 34 claims across 3 drugs.
Dr. Zamarin's Part D claims by kind of drug, 2024
- Generic115 claims88%
- Brand-name15 claims12%
Dr. Zamarin's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 342024: 4841%
Drugs named by CMS: 3 in 2024, 3 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Dmitriy Zamarin offers telehealth to Medicare patients
Dr. Zamarin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zamarin as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Dmitriy Zamarin has 121 publications on record
Dmand AI links 121 papers to Dr. Zamarin, published from 2009 to 2025. 2020 was the busiest year, with 11. The most frequent topics are Ovarian Neoplasms, Immunotherapy and Tumor Microenvironment. Dr. Zamarin has published most often in Gynecol Oncol. Dr. Zamarin's most frequent co-authors are Carol Aghajanian, MD, Nadeem R. Abu-Rustum, MD and Dennis S. Chi, MD.
Dr. Zamarin's papers by year, 2016 to 2025
Topics Dr. Zamarin writes about most
- Ovarian Neoplasms
- Immunotherapy
- Tumor Microenvironment
- Endometrial Neoplasms
- Programmed Cell Death 1 Receptor
- Cell Line, Tumor
- Oncolytic Virotherapy
- Antineoplastic Combined Chemotherapy Protocols
Dr. Zamarin's most frequent co-authors
- Carol Aghajanian, MD32 shared papers
- Nadeem R. Abu-Rustum, MD20 shared papers
- Dennis S. Chi, MD12 shared papers
Recent publications by Dr. Zamarin
Int J Gynecol Cancer
See who Dr. Zamarin researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Zamarin works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Dmitriy Zamarin has worked on 4 clinical trials
Dmand AI links Dr. Zamarin to 4 clinical trials, 2 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Carcinosarcoma, Fallopian Tube Diseases and Uterine Cervical Neoplasms. National Cancer Institute (NCI) sponsors the most, 3.
Clinical trials with Dr. Zamarin by phase
- 2Phase 1: 2 trials
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Zamarin's trials
- Carcinosarcoma
- Fallopian Tube Diseases
- Uterine Cervical Neoplasms
- Fallopian Tube Neoplasms
- Neoplasms, Complex and Mixed
Investigators on the most trials with Dr. Zamarin
- David P. Bender, MD2 shared trials
- Bradley Robert Corr, MD2 shared trials
- Jeffrey Wayne Elder, MD2 shared trials
Recent clinical trials with Dr. Zamarin
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer (opens in a new tab)
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Dmitriy Zamarin received $30,831 in industry payments from 2016 to 2025
CMS Open Payments shows 34 general payments to Dr. Zamarin from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Genentech, Inc. paid the most, $8,620.
General payments to Dr. Zamarin by program year, 2016 to 2025
General payments to Dr. Zamarin by kind, 2016 to 2025
- Consulting fees$20,25066%
- Travel and lodging$9,27230%
- Food and beverage$8093%
- Education speaker fees$5002%
Companies that paid Dr. Zamarin the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Dmitriy Zamarin graduated from Icahn School Of Medicine At Mount Sinai
Dr. Zamarin graduated from Icahn School Of Medicine At Mount Sinai in 2008.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Dmitriy Zamarin's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Dmitriy Zamarin
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Dmitriy Zamarin's NPI number?
Dr. Dmitriy Zamarin's NPI number is 1891955357. It was assigned on June 9, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Dmitriy Zamarin?
Dr. Dmitriy Zamarin is a medical oncologist in Brooklyn, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Dmitriy Zamarin practice?
Dr. Zamarin practices at 3201 Kings Hwy, Brooklyn, NY 11234. Dr. Zamarin's primary practice is Mount Sinai - Brooklyn in Brooklyn, New York. Dmand AI also links Dr. Zamarin to 1 hospital and 1 group practice or clinic.
What is Dr. Dmitriy Zamarin's office phone number?
The practice phone on file for Dr. Zamarin is (646) 605-6009.
What is Dr. Dmitriy Zamarin's medical license number?
Dr. Zamarin holds New York license 254702.
Which hospitals is Dr. Dmitriy Zamarin affiliated with?
Dr. Zamarin is affiliated with The Mount Sinai Hospital. Dmand AI links Dr. Zamarin to 1 more hospital.
What medical group is Dr. Dmitriy Zamarin part of?
Dr. Zamarin is linked to Mount Sinai Institute for Liver Medicine.
Does Dr. Dmitriy Zamarin accept Medicare?
Yes. CMS data shows Dr. Zamarin billed Medicare for 166 services in 2024, and Dr. Zamarin accepts Medicare assignment.
Does Dr. Dmitriy Zamarin offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Zamarin as offering telehealth services.
How many Medicare patients does Dr. Dmitriy Zamarin see?
CMS counts 48 Medicare patients who saw Dr. Zamarin in 2024, with an average age of 73.
Show 7 more questionsShow fewer questions
What services does Dr. Dmitriy Zamarin bill to Medicare?
In 2024, Dr. Zamarin's most billed Medicare services were office visit, established patient (99214), hospital inpatient care (99233) and office visit, new patient (99205).
Where did Dr. Dmitriy Zamarin go to medical school?
Dr. Zamarin graduated from Icahn School Of Medicine At Mount Sinai in 2008.
What drugs does Dr. Dmitriy Zamarin prescribe most?
In 2024 Medicare Part D data, Dr. Zamarin's most prescribed drugs by claims were Ondansetron ODT, Prochlorperazine Maleate and Dexamethasone.
Has Dr. Dmitriy Zamarin received payments from drug or device companies?
CMS Open Payments shows $30,831 in general payments to Dr. Zamarin from 10 companies from 2016 to 2025. The largest total came from Genentech, Inc.
How long has Dr. Dmitriy Zamarin been practicing?
Dr. Zamarin graduated from medical school in 2008, 18 years ago.
Does Dr. Dmitriy Zamarin do research?
Dmand AI links 121 publications to Dr. Zamarin, published from 2009 to 2025. Dr. Zamarin has worked on 4 clinical trials.
Who does Dr. Dmitriy Zamarin publish with?
Dr. Zamarin's most frequent co-authors are Carol Aghajanian, MD (32 shared papers), Nadeem R. Abu-Rustum, MD (20 shared papers) and Dennis S. Chi, MD (12 shared papers).
Selling to medical oncology practices?
See medical oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card